R&D Changing Faces – Board of Directors and Advisory Boards - Oc... From high-profile resignations to the addition of seasoned executives and scientific leaders, last month saw a series of notable changes.
Digital Changing Faces – Digital and supplier hires - October 2025 In the digital and supplier space, we saw a good deal of personnel movement in October, including a number of CEO appointments.
R&D Changing Faces - Pharma and biotech - October 2025 From high-profile resignations to strategic appointments, October was a buzzy month for pharma industry personnel news.
R&D Changing Faces – Boards of Directors and Advisory Boards – A... Welcome back to Changing Faces, in our final round-up for August and September there are plenty of Board appointments to report on.
Sales & Marketing Changing Faces – Agency, investor, and legal hires – August ... In the agency and investor worlds, August and September hires were light volume-wise, but did include big changes at the top of the totem pole.
Digital Changing Faces – Digital and supplier hires – August and Sep... There was plenty of personnel action in August and September among pharmaceutical suppliers, particularly in the clinical trial technology sector.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.